Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neuroprotective therapies.

D K Simon1, D G Standaert

  • 1Neurology Service, Massachusetts General Hospital, Boston, USA.

The Medical Clinics of North America
|March 27, 1999
PubMed
Summary
This summary is machine-generated.

Current Parkinson's disease treatments manage symptoms but don't slow progression. Research into neuroprotective strategies targeting oxidative stress and excitotoxicity offers hope for slowing Parkinson's disease (PD) progression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Border-associated macrophages mediate the neuroinflammatory response in an alpha-synuclein model of Parkinson disease.

Nature communications·2023
Same author

Connectomic Basis for Tremor Control in Stereotactic Radiosurgical Thalamotomy.

AJNR. American journal of neuroradiology·2023
Same author

Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.

Movement disorders : official journal of the Movement Disorder Society·2017
Same author

Striatal cholinergic dysfunction as a unifying theme in the pathophysiology of dystonia.

Progress in neurobiology·2015
Same author

Monocytes and Parkinson's disease: invaders from outside?

Movement disorders : official journal of the Movement Disorder Society·2014
Same author

A full-brain, bootstrapped analysis of diffusion tensor imaging robustly differentiates Parkinson disease from healthy controls.

Neuroinformatics·2014
Same journal

Care Transitions Continue to Evolve.

The Medical clinics of North America·2026
Same journal

Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

The Medical clinics of North America·2026
Same journal

Care Transitions and Value-Based Payment Models in the United States.

The Medical clinics of North America·2026
Same journal

Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

The Medical clinics of North America·2026
Same journal

Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

The Medical clinics of North America·2026
Same journal

Social Determinants of Health: Unique Considerations in Transitions of Care.

The Medical clinics of North America·2026
See all related articles

Area of Science:

  • Neuroscience
  • Neurology
  • Pharmacology

Background:

  • Parkinson's disease (PD) currently lacks treatments that halt its progression.
  • Effective symptomatic therapies are available, but disease-modifying treatments are needed.
  • Understanding neurodegenerative mechanisms is key to developing new therapies.

Purpose of the Study:

  • To review evidence supporting oxidative stress and excitotoxicity as mechanisms in PD.
  • To examine current neuroprotective strategies for Parkinson's disease.
  • To explore potential future therapeutic avenues for PD.

Main Methods:

  • Literature review of studies on PD mechanisms.
  • Analysis of research on neuroprotection in Parkinson's disease.
  • Synthesis of evidence for oxidative stress and excitotoxicity hypotheses.

Related Experiment Videos

Main Results:

  • Evidence supports the roles of oxidative stress and excitotoxicity in PD pathogenesis.
  • Various strategies targeting these mechanisms are under investigation.
  • No current treatment is proven to slow PD progression.

Conclusions:

  • Neuroprotective strategies are a promising area for PD treatment development.
  • Targeting oxidative stress and excitotoxicity may offer disease-modifying benefits.
  • Further research is needed to translate these strategies into clinical practice.